
Please try another search
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins. It develops ORMD-0801, an oral insulin capsule, which is in phase III clinical trial for the treatment of individuals with diabetes. The company has license agreements with Oravax Medical Inc. to commercialize oral vaccines for COVID-19 and other novel coronaviruses. Oramed Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in New York, New York.
Name | Age | Since | Title |
---|---|---|---|
Yehuda Reznick | 76 | 2024 | Director |
Leonard Sank | 60 | 2007 | Independent Director |
Roy Eldor | - | 2016 | Member of the Scientific Advisory Board |
Avram Hershko | 88 | 2008 | Member of Scientific Advisory Board |
Harold Jacob | 71 | 2008 | Member of Scientific Advisory Board |
Eleuterio Ferrannini | - | 2007 | Member of Scientific Advisory Board |
Nadav Kidron | 51 | 2006 | President, CEO & Executive Chairman |
Julio Rosenstock | - | 2020 | Member of Scientific Advisory Board |
Arie Mayer | 69 | 2019 | Independent Director |
G. Alexander Fleming | - | 2019 | Member of Scientific Advisory Board |
Anne L. Peters | - | 2022 | Member of Scientific Advisory Board |
Benjamin Shapiro | 40 | 2023 | Independent Director |
Daniel Aghion | 43 | 2024 | Independent Director |
Jay S. Skyler | 78 | 2020 | Member of Scientific Advisory Board |
Miriam Kidron | 85 | 2006 | Chief Scientific Officer & Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review